Enable JavaScript to visit this website.
Skip directly to content

XELJANZ / XELJANZ XR (tofacitinib)

Product Information

Product Communication

January 12, 2022 Health Product Risk Communication (download PDF, 282KB)

February 24, 2021 Healthcare Professional Communication (download PDF, 798KB)

December 02, 2019 Healthcare Professional Communication (download PDF, 798KB)

Canadian regulations limit the scope of information we are permitted to give on prescription drugs via the Internet or other means. Please consult a qualified health professional for more detailed information.
Please contact Pfizer Canada Medical Information at 1 800 463-6001 with any comments or inquiries.

If you encounter technical difficulties in viewing our product information please contact Pfizer.ca